MRI reports and biopsy pathology reports were extracted from a cohort of 1,360,866 patients with PCa in the VA Cancer Registry System or the VA Corporate Data Warehouse, with 155,570 patients having ...

本研究评估了基于MRI的Node-RADS在诊断结直肠癌淋巴结转移及预后中的价值。纳入2019-2023年163例未接受过抗肿瘤治疗的患者，结果显示Node-RADS诊断效能优于传统标准（AUC 0.912 vs 0.755，敏感度81% vs 75.5%，特异度97.3% vs 71.8%），且评分与术后无病生存期显著相关（C-index ...

Innovative technology performs automatic segmentation and lesion detection in prostate MRI scans to assist in PI-RADS scoring for prostate cancer management TEL AVIV, Israel & SAN JOSE, ...

Phase Ib Study of BI 836880 (VEGF/Ang2 nanobody) in Combination With Ezabenlimab (anti–PD-1 antibody) in Patients With Advanced or Metastatic Solid Tumors A clinical and magnetic resonance imaging ...

More good tidings to gladden the hearts of men who have reached the half century mark: Swapping traditional prostate biopsies for MRI-targeted biopsies with a new prostate cancer risk score can cut ...

At repeat screening, only a low proportion of MRI scans indicated suspicion of clinically significant prostate cancer. Among men receiving their second biennial prostate cancer screening in a Swedish ...

New reporting and data system for standardized evaluation and recording of peripheral nerve pathologies, NS-RADS, validated in multicenter study “The proposed NS-RADS classification is accurate and ...